Overall, our findings indicate that tumor cell-intrinsic BRD9 orchestrates metabolic reprogramming and that BRD9 ablation may be a viable avenue for improving the effectiveness of radiotherapy (Fig. 7M). The gene discussed is BRD9; the disease is neoplasm.